Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination
Introduction Disease-modifying therapies (DMTs) have been shown to improve disease
outcomes in multiple sclerosis (MS) patients. They may also impair the immune response to …
outcomes in multiple sclerosis (MS) patients. They may also impair the immune response to …